Treatment of hypertrophic obstructive cardiomyopathy with verapamil.
Twenty-two patients with hypertrophic obstructive cardiomyopathy were treated with the calcium inhibitor, verapamil, which was administered in a mean oral dose of 480 mg per day. After an average of 15 months of treatment (4 to 24 months), the QRS amplitude in the electrocardiogram was significantly...
保存先:
| 出版年: | Br Heart J |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BMJ Publishing Group
1979
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC482109/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/573129/ https://ncbi.nlm.nih.govhttps://doi.org/10.1136/hrt.42.1.35 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|